Clinical Trial Update: Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED) [Phase 2]

View source ↗

Summary

Phase 2 sleep study of MK0928 in adults with primary insomnia has been terminated. This is a status update for the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK0928

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Primary Insomnia | Phase 2 | Status: TERMINATED